Sale!

ALL FISH Panel: BCR/ABL, TEL/AML1, MLL, E2A Genetic Analysis

Original price was: $496.Current price is: $372.

-25%

The ALL FISH Panel is a comprehensive genetic analysis test specifically designed for acute lymphoblastic leukemia (ALL) diagnosis and monitoring. This advanced molecular test examines four critical genetic markers: BCR/ABL, TEL/AML1, MLL, and E2A, providing crucial information for accurate leukemia classification and treatment planning. The test utilizes Fluorescence In Situ Hybridization (FISH) technology to detect chromosomal abnormalities that drive leukemia development. Healthcare providers recommend this test for patients with suspected or confirmed ALL to guide targeted therapy selection and monitor treatment response. Results are typically available within 10 days from bone marrow or peripheral blood samples. The test is available for $372 USD, offering significant savings from the regular $496 USD price, making advanced genetic testing accessible for comprehensive leukemia management.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

ALL FISH Panel: Comprehensive Genetic Analysis for Leukemia Diagnosis

Understanding the ALL FISH Panel Test

The ALL FISH Panel represents a cutting-edge genetic diagnostic tool specifically engineered for the precise detection and characterization of acute lymphoblastic leukemia (ALL). This sophisticated molecular analysis employs Fluorescence In Situ Hybridization (FISH) technology to examine critical genetic markers that play pivotal roles in leukemia development and progression. By analyzing chromosomal abnormalities at the molecular level, this test provides healthcare providers with essential information for accurate diagnosis, risk stratification, and personalized treatment planning.

What Does the ALL FISH Panel Measure?

The ALL FISH Panel comprehensively evaluates four essential genetic markers:

  • BCR/ABL Fusion Gene: Detects the Philadelphia chromosome translocation, a critical marker associated with poor prognosis in ALL
  • TEL/AML1 Rearrangement: Identifies the most common genetic abnormality in childhood ALL, typically associated with favorable outcomes
  • MLL Gene Rearrangements: Screens for mixed lineage leukemia gene abnormalities linked to aggressive disease forms
  • E2A-PBX1 Fusion: Detects specific translocations that influence treatment response and disease progression

Who Should Consider This Genetic Test?

The ALL FISH Panel is recommended for individuals presenting with:

  • Unexplained fatigue, weakness, or persistent fever
  • Frequent infections or unusual bruising/bleeding
  • Enlarged lymph nodes, spleen, or liver
  • Bone pain or joint discomfort
  • Abnormal complete blood count results suggesting leukemia
  • Newly diagnosed acute lymphoblastic leukemia requiring genetic characterization
  • Patients undergoing treatment monitoring for ALL

Significant Benefits of ALL FISH Panel Testing

Undergoing the ALL FISH Panel offers numerous advantages for comprehensive leukemia management:

  • Precise Diagnosis: Provides definitive genetic confirmation of ALL subtype
  • Risk Stratification: Helps determine disease aggressiveness and prognosis
  • Personalized Treatment: Guides selection of targeted therapies based on genetic markers
  • Treatment Monitoring: Tracks response to therapy and detects minimal residual disease
  • Early Detection: Identifies genetic abnormalities before clinical symptoms manifest
  • Comprehensive Analysis: Simultaneously evaluates multiple critical genetic markers

Understanding Your Test Results

Your ALL FISH Panel results will provide detailed information about the presence or absence of specific genetic abnormalities:

  • Positive Results: Indicate the presence of specific genetic rearrangements, guiding targeted treatment approaches
  • Negative Results: Suggest absence of tested genetic abnormalities, potentially indicating standard-risk ALL
  • Quantitative Data: Provides percentage of cells with specific genetic changes
  • Clinical Correlation: Results should be interpreted by qualified hematologists/oncologists in context of clinical presentation
  • Treatment Implications: Specific genetic findings may influence chemotherapy selection and intensity

Test Pricing and Availability

Test Name Discount Price Regular Price
ALL FISH Panel: BCR/ABL, TEL/AML1, MLL, E2A $372 USD $496 USD

Test Specifications

  • Turnaround Time: 10 days
  • Sample Type: Bone marrow / Peripheral blood (Transport immediately)
  • Test Components: Sodium Heparin Vacutainer (2ml)
  • Pre-test Instructions: Requires Doctor’s prescription (not applicable for surgery, pregnancy, or travel abroad cases)

Nationwide Accessibility

We maintain comprehensive testing facilities across major metropolitan areas throughout the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results with rapid turnaround times.

Take Action for Your Health

Don’t leave your leukemia diagnosis to chance. The ALL FISH Panel provides the genetic clarity needed for optimal treatment decisions. Our experienced genetic counselors and oncology specialists are ready to guide you through the testing process and help interpret your results.

Book your ALL FISH Panel test today by calling +1(267) 388-9828 or schedule your appointment online. Take the first step toward precise leukemia diagnosis and personalized treatment planning.